Multicentre, randomised controlled trial of adjuvant chemotherapy in cervical cancer with residual human papilloma virus DNA following primary radiotherapy or chemoradiotherapy: a study protocol

INTRODUCTION: The role of adjuvant chemotherapy after radical radiotherapy (RT) or chemoradiotherapy (CRT) in cervical cancer awaits further confirmation. Evidences have shown that persistent human papilloma virus (HPV) DNA in exfoliated cell post-RT is a potential biomarker of subclinical residual...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanhong, Ouyang, Yi, Su, Jingjing, Liu, Jing, Cai, Qunrong, Xu, Qin, Bai, Zhigang, Cao, Xinping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797403/
https://www.ncbi.nlm.nih.gov/pubmed/31594870
http://dx.doi.org/10.1136/bmjopen-2018-028171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797403/
https://www.ncbi.nlm.nih.gov/pubmed/31594870
http://dx.doi.org/10.1136/bmjopen-2018-028171

Ejemplares similares